WHO ICTRP trial
Efecto de niacina/laropiprant en la concentración de lipoproteína (A) en…
EUCTR2010-022258-17-ES · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-022258-17-ES |
|---|---|
| Public title | Efecto de niacina/laropiprant en la concentración de lipoproteína (A) en relación a las concentraciones basales y al tamaño de lipoproteína (A). |
| Scientific title | Efecto de niacina/laropiprant en la concentración de lipoproteína (A) en relación a las concentraciones basales y al tamaño de lipoproteína (A). |
| Primary sponsor | Instituto Aragonés de Ciencias de la Salud |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Spain |
| Conditions | Tratamiento de los pacientes con hiperlipemia, especialmente cuando ésta combina hipertrigliceridemia, hipercolesterolemia y HDL-c bajo. MedDRA version: 13 Level: LLT Classification code 10020661 Term: Hiperlipemia |
| Interventions | Trade Name: TREDAPTIVE 1000 mg/20 mg comprimidos de liberación modificada Pharmaceutical Form: Modified-release tablet INN or Proposed INN: LAROPIPRANT Other descriptive name: LAROPIPRANT Concentration unit: mg milligram(s) Concentration… |
| Registration date | Feb 22, 2011 |
| Secondary IDs | EC09/099 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: